Risk factors of recurrent secondary hyperparathyroidism after adequate primary surgical treatment

被引:4
|
作者
Kuo, Yu-Chi [1 ]
Wang, Shang-Yu [1 ,2 ,3 ]
Hung, Yu-Liang [1 ]
Hsu, Chih-Chieh [1 ]
Kou, Hao-Wei [1 ]
Chen, Ming-Yang [1 ]
Tsai, Chun-Yi [1 ]
Chang, Chih-Hsiang [3 ,4 ]
Wang, Yu-Chao [1 ]
Hsu, Jun-Te [1 ,3 ]
Yeh, Ta-Sen [1 ,3 ]
Lee, Wei-Chen [1 ,3 ]
Yeh, Chun-Nan [1 ,3 ]
机构
[1] Linkou Chang Gung Mem Hosp, Dept Surg, Div Gen Surg, Taoyuan City, Taiwan
[2] Chang Gung Univ, Grad Inst Clin Med Sci, Taoyuan City, Taiwan
[3] Chang Gung Univ, Coll Med, Taoyuan City, Taiwan
[4] Linkou Chang Gung Mem Hosp, Kidney Res Ctr, Dept Nephrol, Taoyuan City, Taiwan
来源
FRONTIERS IN ENDOCRINOLOGY | 2023年 / 14卷
关键词
secondary hyperparathyroidism; parathyroidectomy; end-stage renal disease; recurrence; parathyroid; JAPANESE HEMODIALYSIS-PATIENTS; TOTAL PARATHYROIDECTOMY; RENAL-DISEASE; AUTOTRANSPLANTATION; MANAGEMENT; CINACALCET; PTH;
D O I
10.3389/fendo.2023.1063837
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundSecondary hyperparathyroidism (SHPT) is a common condition in patients with end-stage renal disease (ESRD) who are on dialysis. Parathyroidectomy is a treatment for patients when medical therapy has failed. Recurrence may occur and is indicated for further surgery in the era of improved quality of care for ESRD patients. MethodsWe identified, 1060 patients undergoing parathyroidectomy from January, 2011 to June, 2020. After excluding patients without regular check-up at our institute, primary hyperparathyroidism, or malignancy, 504 patients were enrolled. Sixty-two patients (12.3%, 62/504) were then excluded due to persistent SHPT even after the first parathyroidectomy. We aimed to identify risk factors for recurrent SHPT after the first surgery. ResultsDuring the study period, 20% of patients who underwent parathyroidectomy at our institute (in, 2019) was due to recurrence after a previous parathyroidectomy. There were 442 patients eligible for analysis of recurrence after excluding patients with the persistent disease (n = 62). While 44 patients (9.95%) had recurrence, 398 patients did not. Significant risk factors for recurrent SHPT within 5 years after the first parathyroidectomy, including dialysis start time to first operation time < 3 years (p = 0.046), postoperative PTH >106.5 pg/mL (p < 0.001), and postoperative phosphorus> 5.9 mg/dL (p = 0.016), were identified by multivariate analysis. ConclusionsThe starting time of dialysis to first operation time < 3 years in the patients with dialysis, postoperative PTH> 106.5 pg/mL, and postoperative phosphorus> 5.9 mg/dL tended to have a higher risk for recurrent SHPT within 5 years after primary treatment.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Surgical treatment of secondary hyperparathyroidism in elderly patients: an institutional experience
    Andrea Polistena
    Alessandro Sanguinetti
    Roberta Lucchini
    Segio Galasse
    Stefano Avenia
    Massimo Monacelli
    Louis Banka Johnson
    Bengt Jeppsson
    Nicola Avenia
    Aging Clinical and Experimental Research, 2017, 29 : 23 - 28
  • [22] Surgical and Medical Treatment of Secondary Hyperparathyroidism in Patients on Continuous Dialysis
    Tominaga, Yoshihiro
    Matsuoka, Susumu
    Uno, Nobuaki
    WORLD JOURNAL OF SURGERY, 2009, 33 (11) : 2335 - 2342
  • [23] Treatment of secondary and tertiary hyperparathyroidism - surgical viewpoints
    Klempa, I
    CHIRURG, 1999, 70 (10): : 1089 - 1101
  • [24] Total parathyroidectomy without autotransplantation in the surgical treatment of secondary hyperparathyroidism of chronic kidney disease
    Conzo, G.
    Perna, A. F.
    Sinisi, A. A.
    Palazzo, A.
    Stanzione, F.
    Della Pietra, C.
    Livrea, A.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2012, 35 (01) : 8 - 13
  • [25] Total parathyroidectomy without autotransplantation in the surgical treatment of secondary hyperparathyroidism of chronic kidney disease
    Giovanni Conzo
    A. F. Perna
    A. A. Sinisi
    A. Palazzo
    F. Stanzione
    C. Delia Pietra
    A. Livrea
    Journal of Endocrinological Investigation, 2012, 35 : 8 - 13
  • [26] Analysis of the cause and management of persistent laboratory abnormalities occurring after the surgical treatment of primary hyperparathyroidism
    Lee, Ji-Eun
    Hong, Namki
    Kim, Jin Kyong
    Lee, Cho Rok
    Kang, Sang-Wook
    Jeong, Jong Ju
    Nam, Kee-Hyun
    Chung, Woong Youn
    Rhee, Yumie
    ANNALS OF SURGICAL TREATMENT AND RESEARCH, 2022, 103 (01) : 12 - 18
  • [27] Persistent elevation of parathyroid hormone after curative parathyroidectomy: A risk factor for recurrent hyperparathyroidism
    Dream, Sophie
    Kim, Gi Yoon
    Doffek, Kara
    Yen, Tina W. F.
    Carroll, Ty
    Shaker, Joseph
    Evans, Douglas B.
    Wang, Tracy S.
    WORLD JOURNAL OF SURGERY, 2025, 49 (01) : 148 - 158
  • [28] Surgical Treatment of Primary Hyperparathyroidism: Description of Techniques and Advances in the Field
    Khan, Muhammad Adil Abbas
    Rafiq, Sadia
    Lanitis, Sophocles
    Mirza, Farhan Arshad
    Gwozdziewicz, Lukasz
    Al-Mufti, Ragheed
    Hadjiminas, Dimitri J.
    INDIAN JOURNAL OF SURGERY, 2014, 76 (04) : 308 - 315
  • [29] Medical Treatment of Primary, Secondary, and Tertiary Hyperparathyroidism
    Vestergaard, Peter
    Thomsen, Susanna Vid Streym
    CURRENT DRUG SAFETY, 2011, 6 (02) : 108 - 113
  • [30] Treatment sf osteopenia secondary to primary hyperparathyroidism
    Yamaguchi, T
    Sugimoto, T
    Chihara, K
    BIOMEDICINE & PHARMACOTHERAPY, 2000, 54 : 104S - 107S